Last update 07 Nov 2024

Trastuzumab Imbotolimod

Overview

Basic Info

Drug Type
Immune stimulating antibody conjugate (ISAC)
Synonyms
Boltbody ISAC BDC-1001, BDC 1001, BDC-1001
Mechanism
HER2 modulators(Receptor protein-tyrosine kinase erbB-2 modulators), TLR7 agonists(Toll like receptor 7 agonists), TLR8 agonists(Toll like receptor 8 agonists)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Structure

Boost your research with our XDC technology data.
Boost your research with our XDC technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic human epidermal growth factor 2 positive carcinoma of breastPhase 2
US
30 Nov 2023
Metastatic human epidermal growth factor 2 positive carcinoma of breastPhase 2
ES
30 Nov 2023
Advanced Malignant Solid NeoplasmPhase 2
US
24 Feb 2020
Advanced Malignant Solid NeoplasmPhase 2
FR
24 Feb 2020
Advanced Malignant Solid NeoplasmPhase 2
KR
24 Feb 2020
Advanced Malignant Solid NeoplasmPhase 2
ES
24 Feb 2020
HER2 Positive Breast CancerPhase 2
FR
24 Feb 2020
HER2 Positive Breast CancerPhase 2
KR
24 Feb 2020
HER2 Positive Colorectal CancerPhase 2
US
24 Feb 2020
HER2 Positive Colorectal CancerPhase 2
FR
24 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
231
pxzwvcntsq(hieyjmsmov) = hxeeekoevn umnzkcpruz (xmjerdgltq )
Positive
02 Nov 2023
pxzwvcntsq(hieyjmsmov) = bngzpkqfzh umnzkcpruz (xmjerdgltq )
Phase 1/2
Solid tumor
HER2 Expression
131
pkhaajxvgd(eptlzownmn) = gyicfsargr vmvyjuhmvq (fdlklvpfsv )
Positive
23 Oct 2023
pkhaajxvgd(eptlzownmn) = hzmffbqxcb vmvyjuhmvq (fdlklvpfsv )
Phase 1/2
118
cfwoditsaj(okxtrtoeau) = A related SAE (Gr4, bronchopulmonary hemorrhage) was seen in 1 pt (mono, 1.1%). tsnazdvmdt (yqsdhmkibs )
Positive
26 May 2023
Phase 1/2
20
btudtvaztr(gqdizwlxgm) = mild to moderate yyntvmxpsk (bitqdbdxai )
-
28 May 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free